Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data.

Détails

Ressource 1Télécharger: e031156.full_published.pdf (501.56 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_BB3A802F7296
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data.
Périodique
BMJ open
Auteur⸱e⸱s
Luta X., Bagnoud C., Lambiris M., Decollogny A., Eggli Y., Le Pogam M.A., Marques-Vidal P., Marti J.
ISSN
2044-6055 (Electronic)
ISSN-L
2044-6055
Statut éditorial
Publié
Date de publication
06/01/2020
Peer-reviewed
Oui
Volume
10
Numéro
1
Pages
e031156
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
This study aimed to examine the prevalence and determinants of benzodiazepine prescription among older adults in Switzerland, and analyse association with hospitalisation and costs.
Retrospective analysis of claims data.
The study was conducted in nine cantons in Switzerland.
Older adults aged 65 years and older enrolled with a large Swiss health insurance company participated in the study.
The primary outcome was prevalence of benzodiazepine prescription. The secondary outcomes were (1) determinants of any benzodiazepine prescription; (2) the association between any prescription and the probability of hospitalisation for trauma and (3) the association between any prescription and total healthcare expenditures.
Overall, 69 005 individuals were included in the study. Approximately 20% of participants had at least one benzodiazepine prescription in 2017. Prescription prevalence increased with age (65-69: 15.9%; 70-74: 18.4%; 75-80: 22.5%; >80: 25.8%) and was higher in women (25.1%) compared with men (14.6%). Enrollees with the highest deductible of Swiss Francs (CHF) 2500 were 70% less likely to receive a prescription than enrollees with the lowest deductible of CHF 300 (adjusted OR=0.29, 95% CI 0.24 to 0.35).Individuals with at least one prescription had a higher probability of hospitalisation for trauma (OR=1.31, 95% CI 1. 20 to 1.1.44), and 70% higher health care expenditures (β=0.72, 95% CI 0. 67 to 0.77). Enrollees in canton Valais were three times more likely to receive a prescription compared to enrollees from canton Aargau (OR=2.84, 95% 2.51 to 3.21).
The proportion of older adults with at least one benzodiazepine prescription is high, as found in the data of one large Swiss health insurance company. These enrollees are more likely to be hospitalised for trauma and have higher healthcare expenditures. Important differences in prescription prevalence across cantons were observed, suggesting potential overuse. Further research is needed to understand the drivers of variation, prescription patterns across providers, and trends over time.
Mots-clé
benzodiazepine use, claims data, costs, hospitalisations, older adults, prescription
Pubmed
Web of science
Open Access
Oui
Financement(s)
Autre / Swiss Medical Board
Création de la notice
10/01/2020 12:43
Dernière modification de la notice
21/11/2022 9:10
Données d'usage